Psyomics

📍 Cambridge, United Kingdom🗓 Founded 2015👥 20 employees💰 Last funded Jan 2022
Mental Health Care🌐 psyomics.com
Website LinkedIn
At Psyomics, we’re helping people get the mental health support they need, sooner. Led by CEO Dr Melinda Rees, Psyomics aims to revolutionise the way we assess, diagnose, triage, and treat mental health. Cambridge University Biotech spinout turned Healthtech, Psyomics was founded by Professor Sabine Bahn, Laboratory Director at the Cambridge Centre for Neuropsychiatric Research. Following more than six years of research and development, our product — CENSEO — is a digital platform that significantly reduces clinical triage and assessment time through dynamic patient-reported information capture. CENSEO was commercially launched in late 2022 for the assessment and triage of 15+ mental health conditions, used by more than 6,500 patients to date.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Psyomics?
Psyomics has 1 investors on record on gritt.io and 1 late-stage investors.
When did Psyomics last raise funding?
The most recent investment in Psyomics recorded on gritt.io was in January 2022.
When was Psyomics founded?
Psyomics was founded in 2015.
What industry is Psyomics in?
Psyomics operates in Mental Health Care. Find similar Mental Health Care investors on gritt.io.
Where is Psyomics based?
Psyomics is headquartered in Cambridge, United Kingdom.